rss
Thorax doi:10.1136/thoraxjnl-2011-201096
  • Chest clinic
  • Audit update

The relationship between clinical outcomes and medication adherence in difficult-to-control asthma

  1. Ruth H Green1,2,4
  1. 1Institute for Lung Health, Leicester, UK
  2. 2University Hospitals of Leicester NHS Trust, Leicester, UK
  3. 3School of Pharmacy, Grenoble, France
  4. 4Department of Infection, Immunity and Inflammation, University of Leicester, Leicester, UK
  1. Correspondence to Anna C Murphy, Consultant Respiratory Pharmacist, Department of Respiratory Medicine, Glenfield Hospital, Leicester LE3 9QP, UK; anna.murphy{at}uhl-tr.nhs.uk
  • Received 12 September 2011
  • Accepted 29 February 2012
  • Published Online First 21 March 2012

Abstract

Medication non-adherence and the clinical implications in difficult-to-control asthma were audited. Prescription issue data from 115 patients identified sub-optimal adherence (<80%) in 65% of patients on inhaled corticosteroids (ICS) or combined ICS/long-acting β2 agonist (LABA). In those using separate ICS and LABA, adherence to LABA (50%) was significantly better than to ICS (14.3%). Patients with sub-optimal ICS adherence had reduced FEV1 and higher sputum eosinophil counts. Adherence ratio was an independent predictor of previous ventilation for acute severe asthma (p=0.008). The majority of patients with difficult-to-control asthma are non-adherent with their asthma medication. Non-adherence is correlated with poor clinical outcomes.

Footnotes

  • PB and RHG authors are Co-senior authors.

  • Competing interests None to declare.

  • Provenance and peer review Not commissioned; externally peer reviewed.


Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of Thorax.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.